Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.430
-0.030 (-2.05%)
At close: May 19, 2026, 4:00 PM EDT
1.450
+0.020 (1.40%)
After-hours: May 19, 2026, 6:42 PM EDT
Milestone Pharmaceuticals Revenue
Milestone Pharmaceuticals had revenue of $238.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $1.78M. In the year 2025, Milestone Pharmaceuticals had annual revenue of $1.55M.
Revenue (ttm)
$1.78M
Revenue Growth
n/a
P/S Ratio
111.89
Revenue / Employee
$46,947
Employees
38
Market Cap
194.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.00M | -4.00M | -80.00% |
| Dec 31, 2022 | 5.00M | -10.00M | -66.67% |
| Dec 31, 2021 | 15.00M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Arcturus Therapeutics Holdings | 54.71M |
| Keros Therapeutics | 33.18M |
| MediWound | 16.96M |
| Caribou Biosciences | 11.20M |
| Whitehawk Therapeutics | 7.15M |
| Fate Therapeutics | 6.32M |
| Humacyte | 2.02M |
| Cartesian Therapeutics | 1.78M |
MIST News
- 5 days ago - Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 6 days ago - Milestone Pharmaceuticals files $300M mixed securities shelf - TheFly
- 6 days ago - Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c - TheFly
- 6 days ago - Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Milestone Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 days ago - Milestone Pharmaceuticals Earnings release: Q1 2026 - Filings
- 6 days ago - Milestone Pharmaceuticals Registration statement: Registration filing - Filings
- 6 days ago - Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire